Your browser doesn't support javascript.
loading
Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
Terry, Stéphane; Faouzi Zaarour, Rania; Hassan Venkatesh, Goutham; Francis, Amirtharaj; El-Sayed, Walid; Buart, Stéphanie; Bravo, Pamela; Thiery, Jérome; Chouaib, Salem.
Afiliación
  • Terry S; INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine-Univ. Paris-Sud, University Paris-Saclay, Villejuif F-94805, France. stephane.terry@gustaveroussy.fr.
  • Faouzi Zaarour R; Thumbay Research Institute of Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates. dr.rania@gmu.ac.ae.
  • Hassan Venkatesh G; Thumbay Research Institute of Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates. dr.goutham@gmu.ac.ae.
  • Francis A; Thumbay Research Institute of Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates. francis@gmu.ac.ae.
  • El-Sayed W; Thumbay Research Institute of Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates. walidshaaban@gmu.ac.ae.
  • Buart S; INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine-Univ. Paris-Sud, University Paris-Saclay, Villejuif F-94805, France. stephanie.buart@gustaveroussy.fr.
  • Bravo P; INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine-Univ. Paris-Sud, University Paris-Saclay, Villejuif F-94805, France. pamelisa.b@gmail.com.
  • Thiery J; INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine-Univ. Paris-Sud, University Paris-Saclay, Villejuif F-94805, France. jerome.thiery@gustaveroussy.fr.
  • Chouaib S; INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, EPHE, Fac. de médecine-Univ. Paris-Sud, University Paris-Saclay, Villejuif F-94805, France. salem.chouaib@gustaveroussy.fr.
Int J Mol Sci ; 19(10)2018 Oct 06.
Article en En | MEDLINE | ID: mdl-30301213
Hypoxia, or gradients of hypoxia, occurs in most growing solid tumors and may result in pleotropic effects contributing significantly to tumor aggressiveness and therapy resistance. Indeed, the generated hypoxic stress has a strong impact on tumor cell biology. For example, it may contribute to increasing tumor heterogeneity, help cells gain new functional properties and/or select certain cell subpopulations, facilitating the emergence of therapeutic resistant cancer clones, including cancer stem cells coincident with tumor relapse and progression. It controls tumor immunogenicity, immune plasticity, and promotes the differentiation and expansion of immune-suppressive stromal cells. In this context, manipulation of the hypoxic microenvironment may be considered for preventing or reverting the malignant transformation. Here, we review the current knowledge on how hypoxic stress in tumor microenvironments impacts on tumor heterogeneity, plasticity and resistance, with a special interest in the impact on immune resistance and tumor immunogenicity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunomodulación / Microambiente Tumoral / Hipoxia / Neoplasias Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunomodulación / Microambiente Tumoral / Hipoxia / Neoplasias Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article País de afiliación: Francia
...